Hi all – I’m Brandi Brethour, team captain of BB’s Posse and forever friend of run for her. I just returned from the Ovarian Cancer National Alliance (OCNA) 16th annual conference, “Voices of Hope and Strength: Teal is Personal.” As always, it was a great trip: a time to see old friends, make new friends, and remember dear friends as we all came together to hear about recent developments in the ovarian cancer world. A prominent theme of the conference this year was the importance of research and clinical trials. The conference slides are available at www.ovariancancer.org/2013-annual-conference. Our own Dr. Beth Karlan is a member of the OCNA Medical Advisory Board.
The capstone of the conference was Advocacy Day on Capitol Hill where almost 200 people dressed in teal lobbied our legislators for action. We asked Congress to appropriate $20 million to the Department of Defense Ovarian Cancer Research Program to fund important, innovative, research into this disease. Additionally, we asked Congress to pass legislation (HR 1801/no Senate bill yet) giving oral chemotherapy parity with IV chemotherapy. Why is this important? IV chemotherapy is covered under a health plan’s medical benefitand patients are required to pay an office visit copayment. Conversely, in some areas, oral chemotherapy is covered under a prescription benefit with a much higher copayment. As a result, cancer patients may forego their prescribed oral chemotherapy thereby missing important treatments.
I am proud to say that in response to the California delegation’s request, Senator Barbara Boxer agreed to co-sponsor the Senate resolution declaring September “Ovarian Cancer Awareness Month.”
Brandi is a guest blogger and 5-time run for her Team Captain. Catch up with Brandi and the rest of BB’s Posse at the 9th Annual run for her 5K Run & Friendship Walk on November 10!